Immucell (ICCC) Short-term Investments (2010 - 2020)

Immucell (ICCC) has 10 years of Short-term Investments data on file, last reported at $996495.0 in Q4 2020.

• Quarterly Short-term Investments fell 59.83% year-over-year to $996495.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $996495.0 (down 59.83% YoY) and the FY2020 annual result came in at $996495.0, down 59.83% from the prior year.
• Short-term Investments eased to $996495.0 in Q4 2020, from $2.0 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $8.7 million in Q2 2019 to a low of $489582.0 in Q2 2017.
• A 4-year average of $3.9 million and a median of $3.0 million in 2017 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2016 — Short-term Investments jumped 242.07% — and 2017, when it tumbled 92.69%.
• Tracing ICCC's Short-term Investments over 4 years: stood at $5.5 million in 2016, then sank by 91.06% to $489582.0 in 2017, then jumped by 406.71% to $2.5 million in 2019, then plunged by 59.83% to $996495.0 in 2020.
• The last three Short-term Investments figures came in at $996495.0 (Q4 2020), $2.0 million (Q3 2020), and $2.0 million (Q2 2020), per Business Quant data.